Prevention of glucocorticoid-induced osteoporosis with alendronate or alfacalcidol: Relation between change in bone mineral density, bone markers and calcium homeostasis.

被引：0
作者：
Jacobs, JWG
de Nijs, RNJ
Lems, WF
Geusens, PP
Huisman, MAM
Laan, RFJ
Bijlsma, JWJ
机构：
[1] Univ Utrecht, Med Ctr, Utrecht, Netherlands
[2] Free Univ Amsterdam Hosp, Amsterdam, Netherlands
[3] State Univ Limburg Hosp, NL-6201 BX Maastricht, Netherlands
[4] Sint Franciscus Hosp, Rotterdam, Netherlands
[5] Univ Med Ctr, Nijmegen, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [31] GLUCOCORTICOID-INDUCED OSTEOPOROSIS - MECHANISMS FOR BONE LOSS - EVALUATION OF STRATEGIES FOR PREVENTION
    MITCHELL, DR
    LYLES, KW
    JOURNALS OF GERONTOLOGY, 1990, 45 (05): : M153 - M158
  • [32] The stop-study: A randomized placebo controlled trial with alendronate versus alfacalcidol in the prevention of glucocorticoid-induced osteoporosis.
    de Nijs, RNJ
    Jacobs, JWG
    Huisman, MAM
    Buskens, E
    Algra, A
    Lems, WF
    Laan, RFJ
    Geusens, PP
    Bruyn, GAW
    Bijlsma, JWJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S295 - S295
  • [33] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Aysegul Atmaca
    Olcay Gedik
    Advances in Therapy, 2006, 23 : 842 - 853
  • [34] Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients
    B. Shuai
    Y. P. Yang
    L. Shen
    R. Zhu
    X. J. Xu
    C. Ma
    L. Lv
    J. Zhao
    J. H. Rong
    Osteoporosis International, 2015, 26 : 1063 - 1071
  • [35] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Atmaca, Aysegul
    Gedlik, Olcay
    ADVANCES IN THERAPY, 2006, 23 (06) : 842 - 853
  • [36] The therapeutic efficacy of denosumab for the loss of bone mineral density in glucocorticoid-induced osteoporosis: a meta-analysis
    Yamaguchi, Yuta
    Morita, Takayoshi
    Kumanogoh, Atsushi
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2020, 4 (01)
  • [37] Effects of alfacalcidol on bone markers and bone mineral density in alendronate-treated postmenopausal women with osteopenia or osteoporosis: one year interim analysis of the ALFA study
    Boerst, H.
    Bock, O.
    Runge, M.
    Degner, C.
    Stephan-Oelkers, M.
    Umrath, F.
    Armbrecht, G.
    Martus, P.
    Schacht, E.
    Hashimoto, J.
    Felsenberg, D.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S90 - S91
  • [38] Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients
    Shuai, B.
    Yang, Y. P.
    Shen, L.
    Zhu, R.
    Xu, X. J.
    Ma, C.
    Lv, L.
    Zhao, J.
    Rong, J. H.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (03) : 1063 - 1071
  • [39] Correlations between the bone matrix markers and bone mineral density in postmenopausal osteoporosis
    Gurban, C. V.
    Vlad, D. C.
    Zosin, I.
    Gotia, S. R.
    Balas, M.
    Gotia, L.
    Savescu, I. C.
    Radulov, I.
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : 1184 - 1185
  • [40] CORRELATIONS BETWEEN THE MARKERS OF BONE REMODELING AND BONE MINERAL DENSITY IN POSTMENOPAUSAL OSTEOPOROSIS
    Gurban, C.
    Zosin, I.
    Gotia, S.
    Sfrijan, F.
    Gotia, L.
    Radulov, I.
    Savescu, I.
    Drugarin, D.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2010, 6 (01) : 27 - 34
12345